Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma--response to Murphy et al

Affiliations

¹ Programme of Innovative Therapy in Oncology and Haematology, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy. samantha.pozzi@unimore.it.

Free article

Comment

Samantha Pozzi et al. Br J Haematol. 2014 Jun.

Free article

. 2014 Jun;165(6):892.

doi: 10.1111/bjh.12816. Epub 2014 Mar 6.

¹ Programme of Innovative Therapy in Oncology and Haematology, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy. samantha.pozzi@unimore.it.

No abstract available

Keywords: kidney; multiple myeloma; renal insufficiency; survival; therapeutics.

Comment on

Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
Pozzi S, Marcheselli L, Bari A, Liardo EV, Marcheselli R, Luminari S, Quaresima M, Cirilli C, Ferri P, Federico M, Sacchi S. Pozzi S, et al. Br J Haematol. 2013 Oct;163(1):40-6. doi: 10.1111/bjh.12465. Epub 2013 Jul 27. Br J Haematol. 2013. PMID: 23889344
Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma.
Murphy PT, Baldeo C, O'Kelly P, Sargant J, Thornton P, McCloy M, Conlon P, Magee C, Denton M, Quinn J. Murphy PT, et al. Br J Haematol. 2014 Jun;165(6):890-1. doi: 10.1111/bjh.12818. Epub 2014 Mar 5. Br J Haematol. 2014. PMID: 24593674 No abstract available.